Business Context and Reporting Period
Company: ZIMMER BIOMET HOLDINGS, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2019
Event: Entry into a Material Definitive Agreement for a public debt offering.
Key Financial Metrics and Transaction Details
This filing details a specific debt financing transaction rather than reporting operational financial results (revenue, profit, or cash flow) for a fiscal period.
- Instrument: 1.164% Notes due 2027.
- Aggregate Principal Amount: €500 million.
- Interest Rate: 1.164% per annum, payable annually in arrears starting November 15, 2020.
- Maturity Date: November 15, 2027.
- Underwriters: BNP Paribas, J.P. Morgan Securities plc, MUFG Securities EMEA plc, and SMBC Nikko Capital Markets Limited.
- Expected Closing: November 15, 2019.
Material Changes and Use of Proceeds
The filing does not report changes in operational performance. The material change is the expansion of the company's debt capital structure. The Company intends to use the net proceeds from the offering for the following purposes:
- Repayment of the Company's $500 million outstanding aggregate principal amount of 4.625% Senior Notes due 2019 at maturity.
- Repayment of a portion of borrowings outstanding under the Company's unsecured multi-draw term loan facility.
- General corporate purposes.
Guidance, Outlook, and Risks
Management Commentary: The transaction is structured under a sixth supplemental indenture to the Base Indenture dated November 17, 2009. The offering was made pursuant to a Registration Statement on Form S-3.
Risks and Contingencies:
- Closing Risk: The sale of the Notes is subject to the satisfaction of customary closing conditions; the offering may not be consummated on anticipated terms or at all.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the closing and use of proceeds, which are subject to significant risks and uncertainties that could cause actual results to differ materially.
- Underwriter Conflicts: Underwriters and their affiliates have engaged in commercial dealings with the Company and may receive fees or proportionate shares of proceeds used to repay existing debt held by them.
Investor Verification Checklist
- Verify the final closing of the €500 million Notes offering on or around November 15, 2019.
- Confirm the actual allocation of net proceeds between the repayment of the 2019 Senior Notes and the Term Loan facility.
- Review the definitive Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification terms.
- Monitor the Company's subsequent filings for any updates on the repayment of the 4.625% Senior Notes due 2019.